RRML - Evaluation of the impact of vitamin D supplementation on the coagulation profile in mice
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- September 2025 -
 
Romanian Review of Laboratory ... 8
The diagnostic value of lipopr... 5
Assessment of preoperative and... 3
FLT3-ITD DNA allelic burden, b... 3
Monitoring CAR T cells in peri... 3
A comprehensive review of glyc... 3
ATM rs189037 polymorphism: A p... 3
WWP1, TGF β and KLF5 gene exp... 2
Chimerism analysis – critica... 2
Platelet function monitoring t... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Ahead of print DOI:10.2478/rrlm-2025-0022
XML
TXT

Research article

Evaluation of the impact of vitamin D supplementation on the coagulation profile in mice

Mamdouh Allahyani

Correspondence should be addressed to: Mamdouh Allahyani

Abstract:

Background: Vitamin D is an essential molecule involved in several physiological processes and has demonstrated considerable benefit as a medicinal agent. Thus, we aimed to examine the effects of vitamin D supplementation on hematological, coagulation parameters, and liver markers. Methods: Thirty mice were evenly allocated into three groups: the control group, the vitamin D-treated group, and the heparin- treated group. Following a four-month period, body weight, hematological and coagulation parameters, along with liver enzymes, were assessed and examined utilizing one-way ANOVA. Results: Data showed that the mice treated with vitamin D had higher body weights than those in the control group. The data also revealed no significant differences in complete blood count parameters between the mice administered with vitamin D, the controls and the heparin group. However, the levels of prothrombin time (PT) and activated partial thromboplastin time (aPTT) were markedly increased in the vitamin D–treated group relative to the controls and the heparin group. In addition, no significant differences were observed in fibrinogen levels between the three groups. The data also showed that vitamin D supplementation had no major impact on alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) levels with a normal liver architecture. Conclusions: Vitamin D supplementation resulted in prolonged PT and aPTT levels. These findings indicate that vitamin D potentially possesses antithrombotic properties and may be used in thrombotic episodes. A comprehensive assessment of vitamin D impact on the hemostatic system using supplementary indicators for coagulation and thrombosis is necessary.

Keywords: coagulation, liver, thrombosis, vitamin D

Received: 14.6.2025
Accepted: 13.8.2025
Published: 26.8.2025

 
  PDF Download full text PDF
(3890 KB)